Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Genton

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
JAMA|July 21, 1978
Platelet-suppressant therapy in patients with coronary artery diseaseP Steele, J Rainwater, R Vogel, et al.
Stroke|May 1, 1977
Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacksP Steele, J Carroll, D Overfield, et al.
Circulation|April 1, 1976
Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass graftsP Steele, D Battock, G Pappas, et al.
Chest|February 1, 1989
Antithrombotic therapy in peripheral vascular diseaseG P Clagett, E Genton, E W Salzman
Progress in Hematology|January 1, 1975
Critical evaluation of platelet-inhibiting drugs in thrombotic diseaseL A Harker, J Hirsh, M Gent, et al.
Critical Reviews in Clinical Laboratory Sciences|January 1, 1982
Chemistry, measurement, and clinical significance of platelet specific proteinsA C de Boer, E Genton, A G Turpie
The New England Journal of Medicine|December 11, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts)E Genton, M Gent, J Hirsh, et al.
The New England Journal of Medicine|December 18, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts)E Genton, M Gent, J Hirsh, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1982
Platelet consumption in cardiovascular diseaseA G Turpie, A C de Boer, E Genton
The New England Journal of Medicine|December 4, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts)E Genton, M Gent, J Hirsh, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
JAMA|July 21, 1978
Platelet-suppressant therapy in patients with coronary artery diseaseP Steele, J Rainwater, R Vogel, et al.
Stroke|May 1, 1977
Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacksP Steele, J Carroll, D Overfield, et al.
Circulation|April 1, 1976
Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass graftsP Steele, D Battock, G Pappas, et al.
Chest|February 1, 1989
Antithrombotic therapy in peripheral vascular diseaseG P Clagett, E Genton, E W Salzman
Progress in Hematology|January 1, 1975
Critical evaluation of platelet-inhibiting drugs in thrombotic diseaseL A Harker, J Hirsh, M Gent, et al.
Critical Reviews in Clinical Laboratory Sciences|January 1, 1982
Chemistry, measurement, and clinical significance of platelet specific proteinsA C de Boer, E Genton, A G Turpie
The New England Journal of Medicine|December 11, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts)E Genton, M Gent, J Hirsh, et al.
The New England Journal of Medicine|December 18, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts)E Genton, M Gent, J Hirsh, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1982
Platelet consumption in cardiovascular diseaseA G Turpie, A C de Boer, E Genton
The New England Journal of Medicine|December 4, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts)E Genton, M Gent, J Hirsh, et al.
Pageof 9